PeptideDB

SARS-CoV-2 3CLpro-IN-22

CAS: F: C22H23ClN4O3 W: 426.90

SARS-CoV-2 3CLpro-IN-22 (Compound 17) is a cathepsin L (CTSL ) inhibitor with an IC50 value of 32.5 nM. SARS-CoV-2 3CLpr
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity SARS-CoV-2 3CLpro-IN-22 (Compound 17) is a cathepsin L (CTSL ) inhibitor with an IC50 value of 32.5 nM. SARS-CoV-2 3CLpro-IN-22 can be used for the study of SARS-CoV-2 virus[1].
Target IC50: 32.5 nM (cathepsin).
Name SARS-CoV-2 3CLpro-IN-22
Formula C22H23ClN4O3
Molar Mass 426.90
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Ciaglia T, et al. Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization[J]. European Journal of Medicinal Chemistry, 2024: 116128.